BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//BioCatalystFeed//bcf//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:BioCatalystFeed UTHR catalysts
X-WR-CALDESC:Scheduling/reference data from public records\; dates can move
 . Not investment\, legal or medical advice.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:24fb3e516013702bdb1f@biocat.ai
DTSTAMP:20261118T181353Z
DTSTART;VALUE=DATE:20261201
DTEND;VALUE=DATE:20261202
SUMMARY:UTHR P3 readout (est.): A Study Evaluating the Long-Term Efficacy a
 nd Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension
DESCRIPTION:A Study Evaluating the Long-Term Efficacy and Safety of Ralinep
 ag in Subjects With PAH Via an Open-Label Extension\nNCT03683186 | PHASE3 
 | ENROLLING_BY_INVITATION | sponsor: United Therapeutics\nPrimary completi
 on date (ESTIMATED)\; top-line results usually follow later.\nDate precisi
 on: month (shown on the first day)\nTicker UTHR (confidence 0.9)\nSource: 
 https://clinicaltrials.gov/study/NCT03683186\nScheduling/reference data fr
 om public records\; dates can move. Not investment\, legal or medical advi
 ce.
TRANSP:TRANSPARENT
URL:https://clinicaltrials.gov/study/NCT03683186
CATEGORIES:readout,ESTIMATED
END:VEVENT
END:VCALENDAR
